Castleman Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be at least 18 years old.
- You must be HIV-positive with a diagnosed cancer, OR if you are HIV-negative, you must have a newly diagnosed or returning cancer that is scientifically linked to cancers associated with AIDS, such as: classic or transplant-related Kaposi sarcoma, anal cancer, multicentric Castleman's disease, EBV-positive lymphoma, plasmablastic lymphoma, or Hodgkin's lymphoma.
- If you are HIV-positive, your HIV diagnosis must be confirmed through one of the following: a record in your medical records from a healthcare provider; documentation that you have been prescribed HIV treatment (at least two medications); a blood test showing more than 1,000 copies of HIV per mL of blood; or a confirmed HIV antibody test result.
- If you are HIV-positive, you must have a cancer diagnosis or a condition that puts you at higher risk of developing cancer.
- You (or your legal representative) must be able to understand the study and provide written consent to participate.
Who may not be able to join:
- If you are HIV-positive and your only HIV-related medication is a PrEP regimen (such as Truvada taken for prevention only), you may not be eligible (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of biospecimens collected
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.